PIOGLITAZONE HYDROCHLORIDE

N/A

Manufactured by Aurobindo Pharma Limited

3,283 FDA adverse event reports analyzed

Last updated: 2026-04-15

About PIOGLITAZONE HYDROCHLORIDE

PIOGLITAZONE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aurobindo Pharma Limited. The most commonly reported adverse reactions for PIOGLITAZONE HYDROCHLORIDE include DYSPNOEA, DRUG INEFFECTIVE, NAUSEA, PAIN IN EXTREMITY, HYPOGLYCAEMIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PIOGLITAZONE HYDROCHLORIDE.

Top Adverse Reactions

DYSPNOEA85 reports
DRUG INEFFECTIVE68 reports
NAUSEA68 reports
PAIN IN EXTREMITY65 reports
HYPOGLYCAEMIA58 reports
FATIGUE56 reports
DIARRHOEA55 reports
CONDITION AGGRAVATED52 reports
BLOOD GLUCOSE INCREASED51 reports
PNEUMONIA51 reports
ANXIETY50 reports
ACUTE KIDNEY INJURY48 reports
FALL46 reports
OFF LABEL USE45 reports
VOMITING45 reports
DECREASED APPETITE44 reports
HEADACHE40 reports
MALAISE40 reports
THROMBOSIS40 reports
DIZZINESS39 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE39 reports
ASTHENIA38 reports
CONSTIPATION38 reports
PULMONARY EMBOLISM38 reports
CARDIAC FAILURE37 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES37 reports
PYREXIA37 reports
NODULE36 reports
PRODUCTIVE COUGH36 reports
WHEEZING36 reports
ANAEMIA35 reports
ARTERIOSCLEROSIS35 reports
HAEMOPTYSIS35 reports
HYPOTHYROIDISM35 reports
HYPOXIA35 reports
NORMOCHROMIC NORMOCYTIC ANAEMIA35 reports
VASCULITIS35 reports
ARTERIOSCLEROSIS CORONARY ARTERY34 reports
FULL BLOOD COUNT ABNORMAL34 reports
PULMONARY ALVEOLAR HAEMORRHAGE34 reports
PULMONARY VASCULITIS34 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION34 reports
ASTHMA33 reports
BLOOD PRESSURE INCREASED33 reports
CONJUNCTIVITIS ALLERGIC33 reports
DUST ALLERGY33 reports
LUNG DISORDER33 reports
MITE ALLERGY33 reports
SPIROMETRY ABNORMAL33 reports
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS32 reports
MYCOTIC ALLERGY32 reports
NEURITIS32 reports
NEUROLOGICAL SYMPTOM32 reports
OBSTRUCTIVE AIRWAYS DISORDER32 reports
PULMONARY FIBROSIS32 reports
RESPIRATORY SYMPTOM32 reports
PAIN31 reports
ARTHRALGIA30 reports
FORCED EXPIRATORY VOLUME DECREASED30 reports
TOTAL LUNG CAPACITY ABNORMAL30 reports
WEIGHT DECREASED30 reports
WEIGHT INCREASED30 reports
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE28 reports
COVID 1928 reports
HYPERTENSION28 reports
ABDOMINAL PAIN27 reports
ABDOMINAL PAIN UPPER25 reports
HYPERGLYCAEMIA25 reports
SLEEP DISORDER25 reports
ABDOMINAL DISCOMFORT23 reports
BACK PAIN23 reports
DEATH23 reports
HYPOAESTHESIA23 reports
LACTIC ACIDOSIS23 reports
NEUROPATHY PERIPHERAL23 reports
MYOCARDIAL INFARCTION22 reports
OEDEMA PERIPHERAL22 reports
CHEST DISCOMFORT21 reports
DEHYDRATION21 reports
PRODUCT USE ISSUE21 reports
RASH21 reports
CHEST PAIN20 reports
DIABETES MELLITUS20 reports
DRUG INTERACTION20 reports
MUSCULAR WEAKNESS20 reports
RENAL FAILURE20 reports
RENAL FAILURE ACUTE20 reports
WHITE BLOOD CELL COUNT DECREASED20 reports
CAPILLARITIS19 reports
CATARACT19 reports
HYPERKALAEMIA19 reports
HYPOTENSION19 reports
INSOMNIA19 reports
NASOPHARYNGITIS19 reports
PRURITUS19 reports
CARDIAC FAILURE CONGESTIVE18 reports
DIABETES MELLITUS INADEQUATE CONTROL18 reports
DIABETIC KETOACIDOSIS18 reports
GLYCOSYLATED HAEMOGLOBIN INCREASED18 reports
BLADDER CANCER17 reports

Report Outcomes

Out of 1,199 classified reports for PIOGLITAZONE HYDROCHLORIDE:

Serious 85.1%Non-Serious 14.9%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male647 (57.0%)
Female482 (42.5%)
Unknown6 (0.5%)

Reports by Age

Age 6550 reports
Age 6747 reports
Age 7439 reports
Age 7137 reports
Age 6635 reports
Age 7235 reports
Age 7335 reports
Age 6433 reports
Age 6031 reports
Age 7731 reports
Age 7026 reports
Age 5924 reports
Age 6824 reports
Age 6924 reports
Age 7622 reports
Age 6221 reports
Age 6321 reports
Age 7521 reports
Age 5619 reports
Age 5518 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PIOGLITAZONE HYDROCHLORIDE?

This profile reflects 3,283 FDA FAERS reports that mention PIOGLITAZONE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PIOGLITAZONE HYDROCHLORIDE?

Frequently reported terms in FAERS include DYSPNOEA, DRUG INEFFECTIVE, NAUSEA, PAIN IN EXTREMITY, HYPOGLYCAEMIA, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures PIOGLITAZONE HYDROCHLORIDE?

Labeling and FAERS entries often list Aurobindo Pharma Limited in connection with PIOGLITAZONE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.